232
Views
23
CrossRef citations to date
0
Altmetric
Research Article

Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug

, &
Pages 919-928 | Received 03 Jul 2012, Accepted 25 Mar 2013, Published online: 29 Apr 2013

References

  • European Pharmacopoeia. 7th ed.; 2010
  • Kasim N, Whitehouse M, Ramachandran C, et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 2004;1:85–96
  • Fuchs SM, Elsner P. Sulfonamides in dermatology. Dis Mon 2004;50:280–90
  • Vassiliou AA, Papadimitriou SA, Bikiaris DN, et al. Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers. J Control Release 2010;148:388–95
  • Arakawa T, Kita Y, Koyama AH. Solubility enhancement of gluten and organic compounds by arginine. Int J Pharm 2008;355:220–3
  • Bimbo LM, Mäkilä E, Laaksonen T, et al. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 2011;32:2625–33
  • Breda SA, Jimenez-Kairuz AF, Manzo RH, Olivera ME. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives. Int J Pharm 2009;371:106–13
  • Li G, Fan Y, Li X, et al. In vitro and in vivo evaluation of a simple microemulsion formulation for propofol. Int J Pharm 2012;425:53–61
  • Maestrelli F, Cirri M, Mennini N, et al. Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. Eu J Pharm Bio 2011;78:385–93
  • de Araújo MVG, Vieira EKB, Silva Lázaro G, et al. Sulfadiazine/hydroxypropyl-[beta]-cyclodextrin host-guest system: characterization, phase-solubility and molecular modeling. Bioorg Med Chem 2008;16:5788–94
  • Yang B, Lin J, Chen Y, Liu Y. Artemether/hydroxypropyl-[beta]-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode. Bioorg Med Chem 2009;17:6311–17
  • Iohara D, Hirayama F, Ishiguro T, et al. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-[beta]-cyclodextrin solution. Int J Pharm 2008;354:70–6
  • Li N, Wei X, Mei Z, et al. Synthesis and characterization of a novel polyamidoamine–cyclodextrin crosslinked copolymer. Carbohydr Res 2011;346:1721–7
  • Doyagüez EG, Fernández-Mayoralas A. Proline–cyclodextrin conjugates: synthesis and evaluation as catalysts for aldol reaction in water. Tetrahedron 2012;68:7345–54
  • Zhang G, Liang F, Song X, et al. New amphiphilic biodegradable β-cyclodextrin/poly(l-leucine) copolymers: synthesis, characterization, and micellization. Carbohyd Polym 2010;80:885–90
  • Guan Z, Wang Y, Chen Y, et al. Novel approach for synthesis of 2:1 permethylated β-cyclodextrin–C60 conjugate. Tetrahedron 2009;65:1125–9
  • Wang R-Q, Ong T-T, Ng S-C. Synthesis of cationic β-cyclodextrin derivatives and their applications as chiral stationary phases for high-performance liquid chromatography and supercritical fluid chromatography. J Chromatogr A 2008;1203:185–92
  • dos Santos J-FR, Couceiro R, Concheiro A, et al. Poly(hydroxyethyl methacrylate-co-methacrylated-β-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties. Acta Biomater 2008;4:745–55
  • Kutyła MJ, Lambert LK, Davies NM, et al. Cyclodextrin-crosslinked poly(acrylic acid): synthesis, physicochemical characterization and controlled release of diflunisal and fluconazole from hydrogels. Int J Pharm 2013;444:175–84
  • Kumar N, Shishu GB, Bansal G, et al. Preparation and cyclodextrin assisted dissolution rate enhancement of itraconazolium dinitrate salt. Drug Dev Ind Pharm 2013;39:342–51
  • Granero GE, Maitre MM, Garnero C, Longhi MR. Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-[beta]-CD-TEA inclusion complex. Eur J Med Chem 2008;43:464–70
  • Garnero C, Longhi M. Study of ascorbic acid interaction with hydroxypropyl-[beta]-cyclodextrin and triethanolamine, separately and in combination. J Pharmaceut Biomed 2007;45:536–45
  • Zoppi A, Garnero C, Linck YG, et al. Enalapril:[beta]-CD complex: stability enhancement in solid state. Carbohyd Polym 2011;86:716–21
  • Özdemir N, Erkin J. Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. Drug Dev Ind Pharm 2012;38:331–40
  • Lu Y, Zhang T, Tao J, et al. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-β-cyclodextrin. Drug Dev Ind Pharm 2009;35:1452–59
  • Granero GE, Garnero C, Longhi M. The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-[beta]-cyclodextrin. Eur J Pharm Sci 2003;20:285–93
  • Gundogdu E, Koksal C, Karasulu E. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer. Drug Dev Ind Pharm 2012;38:689–96
  • Stefani Borghetti G, Pinheiro Pinto A, Silva Lula I, et al. Daidzein/cyclodextrin/hydrophilic polymer ternary systems. Drug Dev Ind Pharm 2011;37:886–93
  • Mou D, Chen H, Wan J, et al. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm 2011;413:237–44
  • Morand K, Bartoletti AC, Bochot A, et al. Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Int J Pharm 2007;344:150–3
  • Serajuddin ATM. Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007;59:603–16
  • Tarsa PB, Towler CS, Woollam G, Berghausen J. The influence of aqueous content in small scale salt screening – improving hit rate for weakly basic, low solubility drugs. Eur J Pharm Sci 2010;41:23–30
  • Gupta P, Bansal AK. Ternary amorphous composites of celecoxib, poly(vinyl pyrrolidone) and meglumine with enhanced solubility. Die Pharmazie 2005;60:830–6
  • Frézard F, Martins PS, Bahia APCO, et al. Enhanced oral delivery of antimony from meglumine antimoniate/β-cyclodextrin nanoassemblies. Int J Pharm 2008;347:102–8
  • Gupta P, Bansal AK. Modeling of drug release from celecoxib-PVP-meglumine amorphous system. PDA J Pharm Sci Technol 2005;59:346–54
  • Gupta P, Bansal AK. Molecular interactions in celecoxib-PVP-meglumine amorphous system. J Pharm Pharmacol 2005;57:303–10
  • Zoppi A, Quevedo MA, Delrivo A, Longhi MR. Complexation of sulfonamides with β-cyclodextrin studied by experimental and theoretical methods. J Pharm Sci 2009;99:3166–76
  • Higuchi T, Connors K. Phase solubility thechniques. In: Reilly C, ed. Advances in analytical chemistry and instrumentation. New York: Wiley/Interscience; 1965:117–212
  • Ge X, Huang Z, Tian S, et al. Complexation of carbendazim with hydroxypropyl–cyclodextrin to improve solubility and fungicidal activity. Carb Pol 2012;89:208–12
  • Rosa dos Santos J, Couceiro R, Concheiro A, et al. Poly(hydroxyethyl methacrylate-co-methacrylated-b-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties. Acta Biomat 2008;4:745–55
  • Maestrelli F, Cirri M, Mennini N, et al. Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. Eur J Pharm Biopharm 2011;78:385–93
  • Shia JH, Zhoua Yf. Inclusion interaction of chloramphenicol and heptakis (2,6-di-O-methyl)-β-cyclodextrin: phase solubility and spectroscopic methods. Spect Acta Part A 2011;83:570–4
  • Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Dev Rev 2007;59:645–66
  • Qiang Z, Adams C. Potentiometric determination of acid dissociation constants (pKa) for human and veterinary antibiotics. Water research 2004;38:2874–90
  • Basavaraj S, Sihorkar V, Shantha Kumar TR, et al. Bioavailability enhancement of poorly water soluble and weakly acidic new chemical entity with 2-hydroxy propyl-β-cyclodextrin: selection of meglumine, a polyhydroxy base, as a novel ternary component. Pharm Dev Technol 2006;11:443–51
  • Linares M, de Bertorello MM, Longhi M. Solubilization of naphthoquinones by complexation with hydroxypropyl-[beta]-cyclodextrin. Int J Pharm 1997;159:13–18
  • Al Omari MM, Daraghmeh NH, El-Barghouthi MI, et al. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization. J Pharmaceut Biomed 2009;50:449–58
  • Schneider HJ, Hacket F, Rüdiger V. NMR studies of cyclodextrins and cyclodextrin complexes. Chem Rev 1998;98:1755–85
  • Delrivo A, Zoppi A, Longhi MR. Interaction of sulfadiazine with cyclodextrins in aqueous solution and solid state. Carb Pol 2012;87:1980–88
  • Loukas Y, Vraka V, Gregoriadis G. Use of a nonlinear least-squares model for the kinetic determination of the stability constant of cydodextrin inclusion complexes. Int J Pharm 1996;144:225–31
  • Roberts WL, McMurray WJ, Rainey PM. Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime). Antimicrob Agents Chemother 1998;42:1076–82
  • Turczan J, Medwick T. Identification of sulfonamides by NMR spectroscopy. J Pharm Sci 1972;61:434–43
  • Rekharsky M, Goldberg R, Schwarz F, et al. Thermodynamic and nuclear magnetic resonance study of the interactions of α- and β-cyclodextrin with model substances: phenethylamine, ephedrines, and related substances. J Am Chem Soc 1995;117:8830–40
  • Anguiano-Igea S, Otero-Espinar FJ, Vila-Jato JL, Blanco-Méndez J. Interaction of clofibrate with cyclodextrin in solution: phase solubility,1H NMR and molecular modelling studies. Eur J Pharm Sci 1997;5:215–21
  • Linde GA, Laverde Junior A, Vaz de Faria E, et al. The use of 2D NMR to study β-cyclodextrin complexation and debittering of amino acids and peptides. Food Res Int 2010;43:187–92
  • Jullian C, Cifuentes C, Alfaro M, et al. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized β-cyclodextrin. Bioorg Med Chem 2010;18:5025–31
  • Szente L, Osa T, eds., Comprehensive supramolecular chemistry. Vol. 3. Oxford: Pergamon Press; 1996:253–78
  • Clas SD, Dalton CR, Hancock BC. Differential scanning calorimetry: applications in drug development. Pharm Sci Tech Today 1999;2:311–20
  • Li N, Xu L. Thermal analysis of [beta]-cyclodextrin/Berberine chloride inclusion compounds. Thermochim Acta 2010;499:166–70
  • Aignera Z, Berkesib O, Farkasa G, Szabó-Révésza P. DSC, X-ray and FTIR studies of a gemfibrozil/dimethyl–cyclodextrin inclusion complex produced by co-grinding. J Pharm Biomed 2012;57:62–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.